Enzychem Lifesciences Corporation (KOSDAQ:183490)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,069.00
-40.00 (-3.61%)
Apr 2, 2025, 3:30 PM KST

Enzychem Lifesciences Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
88,540113,768154,649139,497457,391869,255
Upgrade
Market Cap Growth
-26.43%-26.43%10.86%-69.50%-47.38%57.11%
Upgrade
Enterprise Value
-22,5263,16216,479-29,937400,389835,243
Upgrade
Last Close Price
1109.001425.001818.001655.009150.0013885.04
Upgrade
PS Ratio
1.171.472.035.2419.9133.67
Upgrade
PB Ratio
0.550.710.800.696.1311.99
Upgrade
P/TBV Ratio
0.730.730.820.706.7312.33
Upgrade
EV/Sales Ratio
0.040.040.22-17.4332.35
Upgrade
Debt / Equity Ratio
0.030.030.030.190.700.59
Upgrade
Asset Turnover
0.390.390.330.140.180.25
Upgrade
Inventory Turnover
5.405.405.802.672.592.82
Upgrade
Quick Ratio
11.0411.0410.634.791.879.72
Upgrade
Current Ratio
13.0313.0312.335.212.0510.73
Upgrade
Return on Equity (ROE)
-12.40%-12.40%-4.74%-18.16%-37.87%-23.90%
Upgrade
Return on Assets (ROA)
-5.21%-5.21%-4.01%-4.81%-10.10%-11.44%
Upgrade
Return on Capital (ROIC)
-5.58%-5.58%-4.19%-5.00%-10.71%-12.40%
Upgrade
Earnings Yield
-24.97%-19.43%-6.03%-17.99%-6.09%-2.01%
Upgrade
FCF Yield
-1.01%-0.79%-8.09%-15.97%-5.34%-1.94%
Upgrade
Buyback Yield / Dilution
3.43%3.43%-7.57%-56.10%-3.93%-3.53%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.